The Advantages of Liquid-Filled Capsules Over Tablets in All Phases of Drug Development
Integrated Bioanalytical Solutions for Simple and Complex Assays
Your Go-To Bioanalytical Team for Simple and Complex Assays
For your simple or most complex assay needs, Altasciences delivers.
With over 25 years of experience, Altasciences provides integrated bioanalytical solutions for your assay needs. How? Our 260+ bioanalytical experts are experienced with a variety of compounds and use the latest instrumentation to deliver quality data quickly.
All bioanalytical solutions are available as stand-alone services to complement your external studies, or as a part of an integrated package with other Altasciences drug development solutions. We offer you complete flexibility.
Our bioanalytical solutions include:
- Analyst support available 24/7 when needed
- State-of-the-art equipment
- Over 650 methods that can be leveraged as an off-the-shelf solution
- Proven regulatory excellence
- Flexible support service offering: scientific writing, project management, TK and PK analysis, and so much more.
Speak with an expert to learn more about our bioanalytical capabilities that best suits your needs.
You may also be interested in the following:
- Fact Sheet: Biomarkers and Biosimilars List
- Fact Sheet: Comprehensive Research Support Services
- Webpage: Bioanalytical Capabilities
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Clinical Sample Kits — We Make It Easy
Clinical Sample Kit Management
From trial sites to our labs, Altasciences’ Material Management Team has over 25 years of experience supporting clinical trials around the globe. We make it easy with efficient collection, preparation and shipment of clinical samples.
Each kit is adapted to your specific study needs, and allows for the storage and shipping of different matrices, such as plasma, urine, serum, and whole blood.
Download our fact sheet to learn more about our capability or send us an e-mail and we will connect you with an expert within 24 hours.
| Download fact sheet | Send e-mail |
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
You may also be interested in the following:
- Webpages:
- Fact Sheet:
Getting a Handle on Highly Potent APIs and Controlled Substances
Manufacturing and Handling Highly Potent APIs and Controlled Substances
With more highly potent APIs (HPAPIs) coming through the R&D pipeline than ever before, it has become increasingly important to partner with the right CDMO to rapidly formulate and manufacture your HPAPIs for preclinical, clinical, and commercial development.
In this Quick Chat video with Ben Reed, learn how Altasciences, a fully integrated CRO/CDMO, handles the most challenging drug substances, from early phase development to commercialization, including:
- Industry-leading technologies used for formulation, containment, and sterilization
- Seamless shipping and handling of your HPAPIs and controlled substances
- Safety procedures and protocols
Have questions? Speak with our experts.
You may also be interested in the following:
- Webpage: Pharmaceutical Contract Manufacturing and Analytical Services
- Webinar: The Development of Nanosuspension Formulations for Poorly Soluble Drugs
- E-Book: The Benefits of Liquid-Filled Capsules in Pharmaceutical Development
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Five Facts About Psychedelics for Mental Health
As the incidence of mental health issues increases around the world, most recently exacerbated by the COVID-19 pandemic that has pushed depression to nearly triple the rate
Take a Look! Four New Nonclinical Posters
We are pleased to share with you the four scientific posters that were presented by our nonclinical experts at the annual SOT meeting.
Detection of Plasma Cells and their Precursors in Bone Marrow and Peripheral Blood
Plasma cells are antibody-producing B cells that play a major role in conferring immune protection, but can also contribute to the pathogenesis of autoimmune diseases like multiple sclerosis, and hematologic cancers like multiple myeloma. Read more.
Evaluating Cytokine Data in Non-human Primate Safety Assessment Studies
Cytokines are cell-signaling small proteins classified as either pro-inflammatory or anti-inflammatory. With the increasing number of biologics and immune-modulating drugs being developed, the evaluation of cytokine levels as potential biomarkers in safety assessment studies has become more common. Read more.
Historical Control Reference Values of Cambodian Cynomolgus Macaque Blood Gases
Measuring blood gases can be useful in identifying drug-related respiratory changes like blood changes in the diffusion of gases from the lungs into the bloodstream. For small molecule pharmaceuticals, ICH S7 identifies hemoglobin oxygen saturation (sO2) as a potential part of the core respiratory battery, while other blood gases (e.g., pO2 and pCO2) can be used for supplemental assessment. Read more.
Multiplexed Cytokine Comparison Across Two Species Dosed with the Same Drug
Questions often asked include which assay platform to use (Meso Scale Discovery or Luminex xMAP®), and how relatable are the results between small animals (e.g.,rats) and large animals (e.g., non-human primates)… Our analysis revealed commonalities and differences in cytokine responses across species. Read more.
Book a consult with one of our experts to discuss how we can support your program.
You may also be interested in the following:
- E-book: Preclinical Assessment Planning Guide
- Webpages:
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.
Q&A: Setting Up Your Clinical Research for Success, With Dr. Nicole Maciolek
Tying together the phases of your drug development program are the essential research support services that help your drug candidates not only meet their milestones, but also regulator
Parallelism Challenges When Using Commercial Kits for Biomarker Quantitation
Top 5 Scientific Resources in CNS Clinical Trials - May 2022
Scientific Resources in CNS Clinical Trials
Altasciences has an extensive understanding of psychiatric and neurologic disorders, stemming from our decades of conducting complex studies in various therapeutic indications impacting the central nervous system.
Here are some of our most insightful scientific resources in the area of CNS drug development:
- The Altascientist: Central Nervous System
Early phase development of CNS-acting drugs is a complex, challenging undertaking. In this article, we provide a detailed overview of the multiple facets you need to consider during the planning and conduct of your CNS-active drug development. Learn More
- The Altascientist: CNS, Psychedelics and Other Schedule I Drugs
In this scientific journal, we uncover the regulatory environment and challenges, the required preclinical and clinical studies specific to Schedule I or Class I (CI) drugs, and the manufacturing considerations for CNS-active drugs. Learn More
- The Altascientist: Studying the Effects of Drugs on Driving
Driving simulation studies are required by the FDA when preclinical and early clinical studies show that a drug may cause somnolence or impair cognition. Discover the challenges of driving simulation clinical testing. Learn More
- Webinar: Navigating the Abuse Potential Evaluation of CNS-active Drugs for EU and U.S. Submissions
In this on-demand webinar, we discuss the key considerations for delivering an integrated preclinical and clinical abuse potential drug development evaluation that meets EMA and FDA regulatory requirements. Watch Now
- Webinar: Inside the Pharmacodynamic Toolbox: How Questionnaires, Models, and Tests of Cognition Can Accelerate the Development of CNS-active Drugs
This session explores the flexible selection of pharmacodynamic measures to enhance the pharmacology, safety, and efficacy. Watch Now
Speak with an expert today to learn more about our CNS solution.
Have five more minutes? Check out these webpages:
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.